Arvind Ravi

Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels

Biagio Ricciuti, Xinan Wang, Joao V. Alessi et al. · JAMA Oncology · 2022 · 384 citations · Full text

Medicine, Cancer Biology, Oncology +17

TRPV4 Channels Mediate Cyclic Strain–Induced Endothelial Cell Reorientation Through Integrin-to-Integrin Signaling

Charles K. Thodeti, Benjamin Matthews, Arvind Ravi et al. · Circulation Research · 2009 · 372 citations · Full text

Life Sciences, Cell Biology, Physiology +17

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Arvind Ravi, Matthew D. Hellmann, Monica Arniella et al. · Nature Genetics · 2023 · 186 citations · Full text

Medicine, Immunology, Oncology +17

RNA-SeQC 2: efficient RNA-seq quality control and quantification for large cohorts

Aaron Graubert, François Aguet, Arvind Ravi et al. · Bioinformatics · 2021 · 136 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +14

Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer

Miguel López de Rodas, Venkata Nagineni, Arvind Ravi et al. · Journal for ImmunoTherapy of Cancer · 2022 · 124 citations · Full text

Life Sciences, Immunology, Oncology +17